Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

Overview of attention for article published in JAMA Oncology, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 47 news outlets
blogs: 2 blogs
twitter: 75 tweeters

facebook: 12 Facebook pages
googleplus: 1 Google+ user
f1000: 1 research highlight platform

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 104 Mendeley

Summary News Blogs Twitter Facebook Google+ Research highlights Dimensions citations

So far, Dimensions has found 91 publications that cite this research output.

91

The most recent citing publications are shown below. View all 91 publications that cite this research output on Dimensions.

Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines

Article in Journal of Oncology (June 2020)

Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?

Article in Gynecologic Oncology (June 2020)

Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer

Article in Current Breast Cancer Reports (June 2020)